Bristol-Myers forecasts 2016 profit above Wall Street estimates
January 28, 2016 at 07:05 AM EST
Jan 27 (Reuters) - Bristol-Myers Squibb Co reported better-than-expected quarterly results, helped by strong sales of its cancer treatments and its Eliquis pill to prevent blood clots, and predicted 2016 earnings slightly above Wall Street forecasts.